Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Change in Receivables (2016 - 2025)

Mesa Laboratories' Change in Receivables history spans 16 years, with the latest figure at $819000.0 for Q4 2025.

  • For Q4 2025, Change in Receivables rose 224.66% year-over-year to $819000.0; the TTM value through Dec 2025 reached $2.1 million, down 35.8%, while the annual FY2025 figure was $2.9 million, 159.21% up from the prior year.
  • Change in Receivables for Q4 2025 was $819000.0 at Mesa Laboratories, down from $1.7 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $4.5 million in Q1 2022 and bottomed at -$6.5 million in Q2 2023.
  • The 5-year median for Change in Receivables is $1.1 million (2022), against an average of $440400.0.
  • The largest annual shift saw Change in Receivables plummeted 535.04% in 2023 before it skyrocketed 2261.97% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $3.3 million in 2021, then crashed by 120.4% to -$678000.0 in 2022, then tumbled by 319.76% to -$2.8 million in 2023, then skyrocketed by 76.91% to -$657000.0 in 2024, then surged by 224.66% to $819000.0 in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Change in Receivables are $819000.0 (Q4 2025), $1.7 million (Q3 2025), and -$3.4 million (Q2 2025).